Feeds:
Posts
Comments

Posts Tagged ‘interviews with notable scientist’

Real Time Coverage @BIOConvention #BIO2019: Keynote: Siddhartha Mukherjee, Oncologist and Pulitzer Author; June 4 9AM Philadelphia PA

Reporter: Stephen J. Williams, PhD. @StephenJWillia2

 

Hematologist and oncologist Siddhartha Mukherjee was born in New Delhi, India. He holds a BS in biology from Stanford University, a DPhil in immunology from Oxford University (where he was a Rhodes Scholar), and an MD from Harvard Medical School. He completed his internal medicine residency and an oncology fellowship at Massachusetts General Hospital. Dr. Murkherjee is an assistant professor of medicine at Columbia University Medical Center. He lives in Manhattan with his wife, artist Sarah Sze, and their two daughters. His Pulitzer Prize-winning book, The Emperor of All Maladies: A Biography of Cancer, tells the story of cancer from its first description in an ancient Egyptian scroll to the gleaming laboratories of modern research institutions. A three-part documentary series based on the book, directed by Barak Goodman and executive produced by Ken Burns, debuts on PBS stations March 30 and continues on March 31 and April 1. The film interweaves a sweeping historical narrative with intimate stories about contemporary patients and an investigation into the latest scientific breakthroughs. He has also written the award winning book “The Gene: An Intimate History” and is Founder of Vor Biopharma, who had just published on their CD33 engineered hematopoetic stem cells as an immunooncology therapy VOR33.

Hon. James C. Greenwood- former Congressional representative and Founder CEO of BIO: moderator

Greenwood: Never have the threats from DC to innovation in the biotech field been so great.  Focused on some great recent innovations and successes in gene therapy.  Although the cost high, father of two LMR retinopathy patients said if his sons had to go through a lifetime of constant care it would cost much more than the gene therapy from Spark cost.  Politicians need to realize that medicines that completely cure diseases are worth much more.  They should meet in the middle with respect to developing a new payer model that will not hurt innovation.

Dr. Mukherjee:  He go into oncology from a virology PhD because he liked to understand the human aspect

of disease.  As an oncologist he gets to interact more closely with patients.  The oncology horizon is always changing.  He likened his view of oncology and cancer as a pyramid with prevention the base, then early detection then therapy at top.

We haven’t found preventable human carcinogens, none that is highly proven causal

This will be the next challenge for cancer researchers, to figure out why we can’t identify these preventable carcinogens.

 

 

 

 

Please follow on Twitter using these @ handles and # hashtags

@Handles

@DrSidMukherjee

@pharma_BI

@AVIVA1950

@BIOConvention

# Hashtags

#BIO2019 (official meeting hashtag)

 

Other Articles on this Open Access Journal on Interviews with Scientific Leaders Include:

Medical Scientific Discoveries for the 21st Century & Interviews with Scientific Leaders at https://www.amazon.com/dp/B078313281 – electronic Table of Contents

Jennifer Doudna and NPR science correspondent Joe Palca, several interviews

Practicing Oncology: Medscape Editor-in-Chief Eric J. Topol, MD interviews Siddhartha Mukherjee, MD, PhD

Eric Topol interviews Al Gore on Genomics and Privacy

Dr. Mercola Interviews Dr. Saul About Beta-Blockers

Volume Two: Medical Scientific Discoveries for the 21st Century & Interviews with Scientific Leaders

 

Read Full Post »

Paul Nurse Interview by Dan Rather

Larry H Bernstein, MD, FCAP, Curator

LPBI

IBIOLOGY NEWSLETTER

CONVERSATIONS IN SCIENCE WITH DAN RATHER: PAUL NURSE

http://www.ibiology.org/bio-films/conversations-in-science-with-dan-rather.html

About the interview
Paul Nurse and Dan Rather have both spent their lives looking at the world and how it works, albeit from very different perspectives. Now the Nobel Prize winning geneticist and esteemed journalist come together for a frank and thoughtful conversation on the state of science and its role in society. Topics include climate change, GMOs, science education, how research spurs economic development, and Dr. Nurse’s own remarkably inspiring and surprising personal history. Funding for this interview was provided by the Lasker Foundation.

Sir Paul Nurse is a leading geneticist, science advocate, and policy maker who has had an major impact on science throughout his career. Nurse won the Nobel Prize in Physiology or Medicine in 2001 for the discovery of the protein cdc2/CDK1, a cyclin-dependent kinase that is the key regulator of the cell cycle. He is currently President of the Royal Society and Chief Executive and Director of the Francis Crick Institute and previously served as President of Rockefeller University. In addition to the Nobel Prize, he has received numerous awards and honors for his vast achievements including the Lasker Award for Basic Medical Research, the Royal Medal, election as a foreign associate into the US National Academy of Sciences, and knighthood.

Dan Rather has a resume that reads like a history book. He has interviewed every American president since Eisenhower and personally covered almost every important global dateline of the last 60 years, from the Civil Rights Movement to Vietnam, to Watergate to the terrorist attacks of 9/11. Rather helped pioneer the very idea that television could be a place for news, and he has kept that spirit of innovation alive by constantly pushing the boundaries of what video storytelling could accomplish. His independent production company News and Guts specializes in high-quality non-fiction content across a range of traditional and digital distribution channels. He has a special interest in telling the stories of science.

 

Read Full Post »

%d bloggers like this: